Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting.
An objective of the present investigation was to prepare and evaluate Eudragit-coated pectin microspheres for colon targeting of 5-fluorouracil (FU). Pectin microspheres were prepared by emulsion dehydration method using different ratios of FU and pectin (1:3 to 1:6), stirring speeds (500-2000 rpm) and emulsifier concentrations (0.75%-1.5% wt/vol). The yield of preparation and the encapsulation efficiencies were high for all pectin microspheres. Microspheres prepared by using drug:polymer ratio 1:4, stirring speed 1000 rpm, and 1.25% wt/vol concentration of emulsifying agent were selected as an optimized formulation. Eudragit-coating of pectin microspheres was performed by oil-in-oil solvent evaporation method using coat:core ratio (5:1). Pectin microspheres and Eudragit-coated pectin microspheres were evaluated for surface morphology, particle size and size distribution, swellability, percentage drug entrapment, and in vitro drug release in simulated gastrointestinal fluids (SGF). The in vitro drug release study of optimized formulation was also performed in simulated colonic fluid in the presence of 2% rat cecal content. Organ distribution study in albino rats was performed to establish the targeting potential of optimized formulation in the colon. The release profile of FU from Eudragit-coated pectin microspheres was pH dependent. In acidic medium, the release rate was much slower; however, the drug was released quickly at pH 7.4. It is concluded from the present investigation that Eudragit-coated pectin microspheres are promising controlled release carriers for colon-targeted delivery of FU.
Paharia
Amol
A
Department of Pharmaceutical Sciences, Dr. Hari Singh Gour University, Sagar, India.
Yadav
Awesh K
AK
Rai
Gopal
G
Jain
Sunil K
SK
Pancholi
Shyam S
SS
Agrawal
Govind P
GP
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics; D002214:Capsules / Q000008:administration & dosage / Q000737:chemistry*; D020099:Coated Materials, Biocompatible / Q000737:chemistry; D003106:Colon / Q000378:metabolism; D004058:Diffusion; D004337:Drug Carriers / Q000737:chemistry; D016503:Drug Delivery Systems / Q000379:methods; D005079:Excipients / Q000737:chemistry*; D005472:Fluorouracil / Q000008:administration & dosage* / Q000737:chemistry* / Q000493:pharmacokinetics; D005766:Gastrointestinal Contents / Q000737:chemistry*; D008863:Microspheres; D010368:Pectins / Q000737:chemistry*; D011109:Polymethacrylic Acids / Q000737:chemistry*
D000964:Antimetabolites, Antineoplastic; D002214:Capsules; D020099:Coated Materials, Biocompatible; D004337:Drug Carriers; D005079:Excipients; D011109:Polymethacrylic Acids; C038300:methylmethacrylate-methacrylic acid copolymer; D010368:Pectins; D005472:Fluorouracil